Bio-Techne Overview
Valuation check: TECH's P/E ratio is 62.03, above the Healthcare sector average of 19.01.
Get informed when a big investor buys or sells
+ Follow62.03
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Bio-Techne (TECH) currently reports a P/E ratio of 62.03. That is above the Healthcare sector average of 19.01. Use the charts on this page to explore Bio-Techne's P/E ratio history and peer comparisons.
Bio-Techne's P/E ratio of 62.03 is higher than the Healthcare sector average of 19.01. That is roughly 226.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Bio-Techne's market price to a fundamental measure such as earnings, sales, or book value. At 62.03, TECH can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 62.03, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.01. From there, open related valuation or income-statement pages for Bio-Techne, and consider following TECH for alerts when major investors trade the stock.
Bio-Techne is classified in the Healthcare sector. On P/E ratio, it currently shows 62.03 versus a sector average near 19.01. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TECH with unrelated industries.
